XML 26 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME/(LOSS) - USD ($)
12 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Apr. 30, 2019
Income Statement [Abstract]      
Net sales (including $2.4 million of related party sales for the four months of our fiscal year 2021 prior to the Separation, and $15.1 million and $17.5 million of related party sales for fiscal year 2020 and 2019, respectively) $ 276,687,000 $ 167,379,000 $ 177,363,000
Cost of sales 149,859,000 96,363,000 93,889,000
Gross profit 126,828,000 71,016,000 83,474,000
Operating expenses:      
Research and development 5,378,000 4,995,000 4,859,000
Selling, marketing, and distribution 56,773,000 38,596,000 31,955,000
General and administrative 41,182,000 41,292,000 50,329,000
Goodwill impairment 0 98,929,000 10,396,000
Total operating expenses 103,333,000 183,812,000 97,539,000
Operating income/(loss) 23,495,000 (112,796,000) (14,065,000)
Other income/(expense), net:      
Other income/(expense), net 497,000 (21,000) 54,000
Interest income/(expense), net 300,000 4,963,000 5,224,000
Total other income/(expense), net 797,000 4,942,000 5,278,000
Income/(loss) from operations before income taxes 24,292,000 (107,854,000) (8,787,000)
Income tax expense/(benefit) 5,887,000 (11,653,000) 734,000
Net income/(loss)/comprehensive income/(loss) $ 18,405,000 $ (96,201,000) $ (9,521,000)
Net income/(loss) per share:      
Basic $ 1.31 $ (6.88) $ (0.68)
Diluted $ 1.29 $ (6.88) $ (0.68)
Weighted average number of common shares outstanding:      
Basic 13,997,000 13,975,000 13,975,000
Diluted 14,225,000 13,975,000 13,975,000